Nexthera Capital »

Amarin Corporation shares owned by Nexthera Capital

Quarter-by-quarter ownership of Amarin Corporation (AMRN) shares owned by Nexthera Capital from 13F filings

Historical chart of Nexthera Capital investment in Amarin Corporation

Tip: Access up to 7 years of quarterly data

All positions including Amarin Corporation held by Nexthera Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amarin Corporation by Nexthera Capital

Quarter filed Position value Share count Share price at filing
2019-06-30 $4.5M 230k 19.39
2019-03-31 $3.1M 149k 20.76

More positions owned by Nexthera Capital

Intercept Pharmaceuticals In
Insmed (INSM)
Audentes Therapeutics
Neurocrine Biosciences (NBIX)
Sarepta Therapeutics (SRPT)
Global Blood Therapeutics In
Immunomedics
Coherus Biosciences (CHRS)
Ascendis Pharma A S (ASND)
Pacira Pharmaceuticals (PCRX)
Urogen Pharma (URGN)
Uniqure Nv (QURE)
Amarin Corporation (AMRN)
Abbvie (ABBV)
Biohaven Pharmaceutical Holding

View all positions for Nexthera Capital

Top funds holding Amarin Corporation

Sarissa Capital Management
Kynam Capital Management
DG Capital Management
Two Sigma Investments
Tang Capital Management
Two Sigma Advisers
Millennium Management
SCP Investment
Price Jennifer C.
Longitude
Citadel Advisors
Hayek-Kallen Investment Management
Axxcess Wealth Management
GSA Capital Partners
Bank Of Montreal

View all funds holding Amarin Corporation